Real-world experience of emicizumab prophylaxis in children with severe haemophilia A: I year follow-up study in egypt

被引：0
|
作者：
Sherief, L. [1 ]
Hassan, A. S. [1 ]
Hamdy, M. [1 ]
Darwish, A. [1 ]
Nazim, A. [1 ]
Hussein, M. A. [1 ]
Elgendy, M. R. [1 ]
El-assy, O. A. [1 ]
机构：
[1] Zagazig Univ, Pediat, Zagazig, Egypt
来源：
HAEMOPHILIA | 2024年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO173
引用
收藏
页码：121 / 121
页数：1
相关论文
共 50 条
  • [1] Real-world data of prophylaxis with emicizumab in children and adolescents with severe haemophilia: A single centre experience
    Michalopoulou, A.
    Dettoraki, A.
    Karelioti, H.
    Thymianou, S.
    Papageorgiou, N.
    Stamati, I.
    Saslis, S.
    Kapsimali, Z.
    Pergantou, H.
    [J]. HAEMOPHILIA, 2024, 30 : 61 - 61
  • [2] Emicizumab prophylaxis: Prospective longitudinal real-world follow-up and monitoring
    Barg, Assaf A.
    Budnik, Ivan
    Avishai, Einat
    Brutman-Barazani, Tami
    Bashari, Dalia
    Misgav, Mudi
    Lubetsky, Aaron
    Kuperman, Amir A.
    Livnat, Tami
    Kenet, Gili
    [J]. HAEMOPHILIA, 2021, 27 (03) : 383 - 391
  • [3] Real-world experience of emicizumab prophylaxis in young children with haemophilia A in China: retrospective data from China
    Huang, Kun
    Liu, Guoqing
    Wu, Runhui
    Chen, Zhenping
    Zhen, Yingzi
    Wu, Xinyi
    [J]. HAEMOPHILIA, 2022, 28 : 50 - 50
  • [4] Real-world experience on the tolerability and safety of emicizumab prophylaxis in paediatric patients with severe haemophilia A with and without FVIII inhibitors
    Hassan, Eman
    Jonathan, Lancashire
    Jayashree, Motwani
    [J]. HAEMOPHILIA, 2021, 27 (06) : E698 - E703
  • [5] INVASIVE PROCEDURES IN PATIENTS WITH HAEMOPHILIA ON EMICIZUMAB PROPHYLAXIS: REAL-WORLD CLINICAL EXPERIENCE IN SLOVENIA
    Rener, K.
    Pompe, B.
    Doma, S. Anzej
    Kotnik, B. Faganel
    Kitanovski, L.
    Zupan, I. Preloznik
    [J]. HAEMOPHILIA, 2022, 28 : 66 - 66
  • [6] Target joint in a patient with severe haemophilia A on emicizumab prophylaxis: Follow-up of 24 weeks
    Arocena, Maria
    Petraccia, Carlos
    Inguanzo, Marianella
    Fraga, Maria Laura
    del Rosario Gomez, Maria
    Gonzalez, Jimena
    Lemos, Felipe
    Boggia, Beatriz
    [J]. HAEMOPHILIA, 2023, 29 : 44 - 45
  • [7] Transitioning patients with severe haemophilia A from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: Real-world clinical experience
    Klamroth, Robert
    Gottstein, Saskia
    [J]. HAEMOPHILIA, 2024,
  • [8] EMICIZUMAB PROPHYLAXIS IN HAEMOPHILIA A WITH AND WITHOUT INHIBITORS: REAL-WORLD DATA FROM SLOVENIA
    Rener, K.
    Doma, S. Anzej
    Kotnik, B. Faganel
    Kitanovski, L.
    Fink, M.
    Zupan, I. Preloznik
    [J]. HAEMOPHILIA, 2021, 27 : 70 - 70
  • [9] Breaking barriers in haemophilia A care: 1-year real-world experience with emicizumab prophylaxis at civil service hospital, Kathmandu, Nepal
    Poudyal, Bishesh Sharma
    Rajbahak, Jagat Man
    [J]. HAEMOPHILIA, 2024, 30 : 97 - 97
  • [10] Real-world data about Bleeding outcomes and joint health of paediatric severe haemophilia A patients on emicizumab prophylaxis
    Hassan, Eman
    Motwani, Jayashree
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 30 - 30
12345